Hemispherx BioPharma Inc. (HEB) Fundamentals

Hemispherx Biopharma Inc is a US-based specialty pharmaceutical company. It is engaged in the clinical development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune-based disorders. The products of the firm are Alferon N Injection and the experimental therapeutic Ampligen. Alferon N Injection is approved for a category of STD infection, and Ampligen represents a RNA being developed for viral diseases and disorders of the immune system. The sales revenue of the company is derived from the United States.
SHARE INFORMATION
Market CapUS$ 4 395 652
Shares Outstanding2 442 029
Float-
Percent Float0,0%
Short Interest120 646,00
Short Percent Float5,2%
Short Interest Ratio0,84
Short Interest Date2019-08-15
Latest Fiscal Dividend Per ShareUS$ 0,00
Latest Fiscal RevenueUS$ 367 000
Latest Fiscal EPSUS$ -9,86
Latest Fiscal Date2018-12-31
DIVIDENDS
Dividend (3 Years)US$ 0,00
Dividend (5 Years)US$ 0,00
Ex Dividend Date-
Dividend RateUS$ 0,00
Dividend Yield0,0%
Payment Cash-
HOLDERS
Institutions26
Institutional Holdings Date2019-07-31
Institutional Bought Previous 3 Months114 292
Institutional Holdings Percent0,9%
Institutional Sold Previous 3 Months74 834
Insider Holdings Date2019-07-31
Insider Bought Previous 3 Months876 726
Insider Holdings Percent0,0
Insider Sold Previous 3 Months-
Insider Shares Owned4 008 023
TRADING INFO
52 Week HighUS$ 14,81
52 Week LowUS$ 1,69
52 Week High ChangeUS$ -85,75
21 Day Moving AverageUS$ 1,9463
21 Day Extended Moving AverageUS$ 2,0947
50 Day Moving AverageUS$ 2,9593
50 Day Extended Moving AverageUS$ 2,9406
200 Day Moving AverageUS$ 6,6733
200 Day Extended Moving AverageUS$ 6,3472
10 Day Average Volume35 217
20 Day Average Volume112 046
30 Day Average Volume111 086
50 Day Average Volume121 989
Alpha-0.059192
Beta0.8706
Standard Deviation0.184165
R20.026604
7 Day Price ChangeUS$ -0,13
7 Day Percent Change-6,74%
21 Day Price ChangeUS$ -0,19
21 Day Percent Change-9,55%
30 Day Price ChangeUS$ -0,82
30 Day Percent Change-31,3%
Month to Date Price ChangeUS$ -0,55
Month to Date Percent Change-23,4%
Quarter to Date Price ChangeUS$ -2,59
Quarter to Date Percent Change-59,0%
180 Day Price ChangeUS$ -6,12
180 Day Percent Change-77,27%
200 Day Price ChangeUS$ -8,76
200 Day Percent Change-82,95%
Year to Date Price ChangeUS$ -6,16
Year to Date Percent Change-77,4%

Hemispherx BioPharma Inc. (HEB) Key Ratios

PROFITABILITY
EBIT Margin-3 071,7%
EBITDA Margin-2 804,9%
Pre-Tax Profit Margin-6 605,4%
Profit Margin Count0,0%
Gross Margin-204,9%
Profit Margin TOT0,0%
INCOME STATEMENTS
RevenueUS$ 307 000
Revenue Per ShareUS$ 0,1257
Revenue (3 Years)US$ 50,83
Revenue (5 Years)US$ 18,35
FINANCIAL STRENGTH
Price to Tangible Book1,10
Total Debt To Equity0,90
Int Coverage-14,50
Current Ratio2,10
Leverage Ratio3,20
Quick Ratio1,70
Long Term Debt To Capital0,41
VALUATION MEASURES
PE Ratio0,00
Enterprise ValueUS$ 7 786 173
Price to Sales14,3181
Price to Free Cash-0,50
PE High Last 5 Years0,00
Price To Book0,90
Price To Cash Flow0,00
PE Low Last 5 Years0,00
Price to Tangible Book1,10
MANAGEMENT EFFECTIVENESS
Receivables Turnover3,00
Invoice Turnover0,00
Assets Turnover0,00
Return Assets-68,37
Return on Equity-139,80
Return on Capital-86,21

Hemispherx BioPharma Inc. (HEB) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorMorrison, Brown, Argiz & Farra, LLC
CEOThomas K. Equels
Emplyoees33
Last AuditUQ
CIK0000946644
IndustryBiotechnology
SectorHealthcare
NAICSBiological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
Address2117 SW Highway 484
Suite B
Ocala, FL 34473
Websitehttps://www.hemispherx.net
Facsimile+1 305 839-2050
Telephone+1 215 988-0080
Emailinfo@hemispherx.net
Dernières Valeurs Consultées
AMEX
HEB
Hemispherx..
Inscrivez-vous aujourd'hui pour consulter ce titre en streaming sur le Moniteur ADVFN. Vous pourrez ajouter et visualiser jusqu'à 110 des vos actions préférée et c'est complètement gratuit..

Se connecter à ADVFN
S'inscrire maintenant
Les cours EURONEXT (CAC 40, etc. ) et FOREX (les devises) sont en direct si connecté.
NYSE, AMEX, et ASX sont en différé d'environ 20 minutes. Les autres cours sont en différé d'environ 15 minutes.

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

P: V:fr D:20230205 03:39:26